EI
ACIU icon

EFG International’s AC Immune ACIU Stock Holding History

EFG International’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6K Hold
9,900
– – ﹤0.01% 870
2026
Q1 		$27.2K Sell
9,900
-3,000
-23% -$9.32K ﹤0.01% 797
2025
Q4 		$40.5K Buy
+12,900
New +$40.7K ﹤0.01% 694

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EFG International's ACIU Position: Q2 2026 in Review

EFG International held its AC Immune (ACIU) position steady in Q2 2026 at 9,900 shares worth $23.6K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

EFG International first reported a position in ACIU in Q4 2025 and has held it in 3 quarters since. The position peaked at $40.5K in Q4 2025. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • EFG International held 9,900 shares of AC Immune worth $23.6K as of Q2 2026.
  • EFG International left its AC Immune share count unchanged in Q2 2026.
  • AC Immune made up ﹤0.01% of EFG International's portfolio in Q2 2026, its #870 holding.
  • EFG International first reported a position in AC Immune in Q4 2025 and has held it in 3 quarters since.
  • EFG International's AC Immune position peaked at $40.5K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on EFG International's 13F filing for Q2 2026, filed 14 Aug 2026.